Showing results (441-450 of 7,003) with videos related to
Sort By:
Pageof 701
Lung Cancer (Amsterdam, Netherlands)|April 15, 2005
Detection of autoantibodies to livin and survivin in Sera from lung cancer patientsAtsuhito Yagihashi, Koichi Asanuma, Daisuke Kobayashi, et al.Lung Cancer (Amsterdam, Netherlands)|April 15, 2005
Tumour CEA as predictor of better outcome in squamous cell carcinoma of the lungGiulia Veronesi, Giuseppe Pelosi, Angelica Sonzogni, et al.Lung Cancer (Amsterdam, Netherlands)|November 16, 2004
The multi-targeted kinase inhibitor SU5416 inhibits small cell lung cancer growth and angiogenesis, in part by blocking Kit-mediated VEGF expressionJulie Litz, G Sakuntala Warshamana-Greene, Geoffrey Sulanke, et al.Lung Cancer (Amsterdam, Netherlands)|November 16, 2004
Expression of survivin mRNA and livin mRNA in non-small-cell lung cancerHiromi Tanabe, Atsuhito Yagihashi, Naoki Tsuji, et al.Lung Cancer (Amsterdam, Netherlands)|November 16, 2004
Translating biomarkers into clinical practice: prognostic implications of cyclophilin A and macrophage migratory inhibitory factor identified from protein expression profiles in non-small cell lung cancerBrandon A Howard, Zhong Zheng, Michael J Campa, et al.Lung Cancer (Amsterdam, Netherlands)|November 16, 2004
High serum YKL-40 level in patients with small cell lung cancer is related to early deathJulia S Johansen, Lars Drivsholm, Paul A Price, et al.Lung Cancer (Amsterdam, Netherlands)|November 16, 2004
Synchronous lesions detected by autofluorescence bronchoscopy in patients with high-grade preinvasive lesions and occult invasive squamous cell carcinoma of the proximal airwaysPhilippe Piérard, Jean Faber, Jacques Hutsebaut, et al.Lung Cancer (Amsterdam, Netherlands)|November 16, 2004
Results of a Phase II study of carboplatin plus gemcitabine in patients with untreated extensive small cell lung cancerMarcus Neubauer, Ralph Heaven, Jairo Olivares, et al.Lung Cancer (Amsterdam, Netherlands)|November 16, 2004
Carcinoma in situ from the view of complete resectionCemal Asim Kutlu, Nur Urer, Guven OlgacLung Cancer (Amsterdam, Netherlands)|November 16, 2004
Epithelial-directed drug delivery: influence of formulation and delivery devicesJames L Mulshine, Len NeckersPageof 701